Phibro Animal Health Corporation
PAHC
$39.45
$0.380.97%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 2,190.43% | 148.42% | 150.00% | 187.02% | -93.46% |
Total Depreciation and Amortization | 41.53% | 37.19% | 29.90% | 1.50% | 9.07% |
Total Amortization of Deferred Charges | 17.51% | 120.00% | 93.85% | 41.15% | 1.68% |
Total Other Non-Cash Items | 298.54% | -82.76% | 221.48% | -147.37% | 61.24% |
Change in Net Operating Assets | -168.22% | 182.07% | -191.20% | -36.57% | 204.37% |
Cash from Operations | -25.17% | 278.28% | -90.25% | -22.08% | 40.47% |
Capital Expenditure | -0.54% | 20.40% | 28.62% | -28.18% | -20.03% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -2,493.18% | -8,643.99% | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -80.84% | -187.38% | 460.95% | 184.47% | 550.41% |
Cash from Investing | 22.80% | -1,715.13% | -947.72% | 80.91% | 11.39% |
Total Debt Issued | -53.29% | 30.65% | 1,045.24% | 1,011.76% | 41.85% |
Total Debt Repaid | 45.37% | -101.61% | -294.92% | -1,243.27% | -36.53% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.06% | -0.10% | 0.02% | 0.00% | 0.00% |
Other Financing Activities | 95.00% | -258.12% | -11.85% | -608.57% | 419.21% |
Cash from Financing | -534.58% | -763.84% | 1,979.09% | -2,352.85% | 128.22% |
Foreign Exchange rate Adjustments | 269.18% | 537.96% | -69.47% | 369.00% | -271.12% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -62.31% | -138.95% | 249.63% | -1,102.99% | 404.28% |